ABCAM PLC has a total of 24 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology and measurement are BIOREN INC, INNOVATIVE TARGETING SOLUTIONS INC and PRESTIGE BIOPHARMA PTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | United Kingdom | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kiss Margaret | 12 |
#2 | Weiner Michael | 12 |
#3 | Couto Fernando Jose Rebelo Do | 6 |
#4 | Zhao Qi | 6 |
#5 | Villanueva Jacinto | 2 |
#6 | Mahrat Reem | 2 |
#7 | Tsai Ruby Yanru | 1 |
#8 | Fernando Jose Rebelo Do Couto | 1 |
Publication | Filing date | Title |
---|---|---|
GB202012722D0 | Validation method | |
WO2019025865A2 | Methods and compositions for ligand directed antibody design | |
WO2019025866A2 | Methods and compositions for the development of antibodies specific to epitope post-translational modification status | |
US2020157190A1 | Monovalent and divalent binding proteins | |
GB2533552A | A method for producing a recombinant allotype-specific rabbit monoclonal antibody | |
GB0911145D0 | A transporatble vessel holder |